(Q64880486)

English

Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Long-term efficacy of infliximab treatment and the predictors of treatment outcomes in patients with refractory uveitis associated with Behçet's disease. (English)

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

1 reference

based on heuristic

inferred from title

author name string

Sho Ueda

1

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Mitsuteru Akahoshi

2

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Atsunobu Takeda

3

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Yasushi Inoue

4

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Aya Omoto

5

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Masahiro Ayano

6

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Yasutaka Kimoto

7

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Hiroki Mitoma

8

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Yojiro Arinobu

9

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Hiroaki Niiro

10

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Hiroshi Tsukamoto

11

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Takahiko Horiuchi

12

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Shin-Ichi Hikita

13

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Takako Fukuhara

14

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Tatsuro Ishibashi

15

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Koh-Hei Sonoda

16

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Koichi Akashi

17

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

publication date

1 March 2018

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

European journal of rheumatology

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

5

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

1

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

9-15

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Serum levels of interleukin-8 in patients with Behcet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 8 in Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endotoxin-induced uveitis is partially inhibited by anti-IL-8 antibody treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behçet's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MCP-1 expression in endotoxin-induced uveitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma and whole-blood chemokine levels in patients with Behcet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uveitis in Behçet disease: an analysis of 880 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behcet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum interleukin-8 as a serologic marker of activity in Behçet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular features of Behcet's disease: an international collaborative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide D

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of regulatory T cells by infliximab in Behcet's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNF- therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-tumor necrosis factor-α therapy in uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of anti-drug antibodies to biologic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/30501852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.5152/EURJRHEUM.2017.17068

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

1 reference

Europe PubMed Central

30 June 2019

http://europepmc.org/abstract/PMC/6063306

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64880486&oldid=1578045580"